Intellikine
	Developer of small molecule drugs that target signal transduction networks for the treatment of cancer, inflammation, and autoimmune disorders. The company\'s products include INK128, an orally-available TORC1/2 inhibitor for the treatment of solid tumor malignancies; INK1197, a small molecule dual PI3K selective inhibitor for patients with immune-mediated inflammatory diseases, such as rheumatoid arthritis and asthma; and PI3K selective inhibitors for the treatment of hematologic malignancies and solid tumors.
	['', 'small molecule drug', ' ', 'cancer drug', ' ', 'drug for autoimmune disorder', ' ', 'treatment of solid tumor malignancie', '']
Vantia
	Developer of small molecule drugs. The company develops drugs for the treatment of nocturia, dysmenorrhoea, respiratory disorders, inflammation, oncological and fibrotic diseases.
	['', 'drug development', ' ', 'nocturia treatment', ' ', 'fibrotic disease treatment', '']
Neuromed Pharmaceuticals
	Provider of small molecule drugs for the Biopharmaceutical industry. The company develops drugs targeting neuronal calcium channels to treat neurological disorders with the initial emphasis on chronic pain anxiety and stroke.
	['therapy ', 'drug developer', ' calcium']
InnoPharma
	Developer of complex generic and innovative specialty pharmaceutical/bio-pharmaceutical products in injectable and ophthalmic dosage forms. The company has a broad portfolio of products under development, with formulations including, suspension, lyophilized, emulsions, liposomes, micelles and lipid complexes.
	['', 'medical product', ' ', 'drug development', ' ', 'bio pharmaceutical product', ' ', 'medical drug research', ' ', 'sterile injectable product', ' ', 'sterile products', ' injectable ophthalmic']
Genemedicine
	Developer of bio-pharmaceutical products. The company designs gene medicines to produce sustained levels of therapeutic proteins within the body. The company develops therapeutic products for both acute and chronic use and to be administered to patients through conventional means such as intramuscular or intravenous injection, or inhalation.
	['biopharmaceutical genes']
Intercept Pharmaceuticals
	Developer of small molecule drugs for the treatment of chronic liver and metabolic diseases. The company develops therapeutics to treat orphan and more prevalent liver diseases in bile acid chemistry.
	['', 'molecule drug', ' ', 'chronic liver treatment', ' ', 'metabolic disease treatment', '']
Kinaxo Biotechnologies
	Developer of spectrum-specific kinase inhibitors. The company operates as a service company specializing in chemical proteomics methods to support the development of small molecule drugs. The company spun out of the Max Planck Institute of Biochemistry.
	['', 'kinase inhibitors', 'inhibitors', 'chemical proteomics', ' ', 'molecule drugs', '']
KeyNeurotek Pharmaceuticals
	Provider of bio pharmaceutical products. The company provides for development and marketing of small molecule drugs for the treatment of neuronal and autoimmune diseases.
	['', 'bio pharmaceutical product', ' ', 'molecule drug', ' ', 'autoimmune disease', '']
